Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
CC transcript
Inv. presentation
Quarterly results
Director departure

Emergent BioSolutions Inc. (EBS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G/A STATE STREET CORP reports a 2.2% stake in EXIT FILING EMERGENT BIOSOLUTIONS INC
10/10/2023 SC 13G/A VANGUARD GROUP INC reports a 5.1% stake in Emergent BioSolutions Inc.
10/05/2023 4 Fowler Neal Franklin (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 118,670 shares @ $0
10/05/2023 4 DeGolyer Donald W (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 118,670 shares @ $0
10/05/2023 3 Fowler Neal Franklin (Director) has filed a Form 3 on Emergent BioSolutions Inc.
10/05/2023 3 DeGolyer Donald W (Director) has filed a Form 3 on Emergent BioSolutions Inc.
10/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
10/02/2023 8-K Quarterly results
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Emergent’s Statement Regarding the Passing of a Director of the Board"
08/15/2023 3 Hartzel William (SVP, Bioservices) has filed a Form 3 on Emergent BioSolutions Inc.
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR SECOND QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q2 2023"
08/08/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position"
07/31/2023 8-K Quarterly results
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT. 11."
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 8-K Quarterly results
07/18/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
06/05/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/31/2023 8-K Investor presentation
Docs: "Emergent BioSolutions Inc. 2023 Annual Meeting of Stockholders May 25, 2023 Agenda 22023 Virtual Annual Meeting of Stockholders INTRODUCTION 1. Call to"
05/30/2023 4 Zoon Kathryn C (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 Hauer Jerome M (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 Richard Ronald (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 Katkin Keith (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 Harsanyi Zsolt (Chairman) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/30/2023 4 Dayal Sujata Tyagi (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/15/2023 8-K Asset disposition
Docs: "Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic GAITHERSBURG, Md., May 15, 2023",
"Unaudited Pro Forma Condensed Consolidated Financial Information"
05/09/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR FIRST QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q1 2023"
04/24/2023 DEFR14A Form DEFR14A - Revised definitive proxy soliciting materials:
04/17/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy